Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,400 | 96,900 | 132,100 | 76,000 | 102,800 |
| Marketable Securities | 4,900 | 7,400 | 8,800 | 10,300 | 18,800 |
| Receivables | 117,800 | 118,100 | 114,300 | 115,200 | 111,700 |
| Inventories | 26,100 | 24,600 | 22,000 | 25,100 | 22,500 |
| Other current assets | 10,400 | 0 | 0 | 0 | 0 |
| TOTAL | $291,600 | $290,300 | $313,600 | $265,400 | $294,300 |
| Non-Current Assets | |||||
| PPE Net | 116,300 | 118,500 | 119,000 | 120,700 | 112,000 |
| Investments And Advances | 0 | 0 | 0 | 0 | 6,200 |
| Intangibles | 605,800 | 627,900 | 636,900 | 643,200 | 646,000 |
| Other Non-Current Assets | 71,400 | 73,800 | 77,000 | 119,800 | 128,700 |
| TOTAL | $793,500 | $820,200 | $832,900 | $883,700 | $892,900 |
| Total Assets | $1,085,100 | $1,110,500 | $1,146,500 | $1,149,100 | $1,187,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,300 | 33,100 | 25,800 | 33,900 | 39,800 |
| Accrued Expenses | 98,300 | 99,200 | 113,900 | 157,600 | 164,300 |
| Other current liabilities | 4,000 | N/A | N/A | N/A | N/A |
| TOTAL | $148,900 | $146,100 | $155,900 | $209,300 | $221,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,800 | 38,700 | 38,500 | 38,500 | 38,400 |
| Other Non-Current Liabilities | 156,900 | 165,700 | 168,900 | 215,200 | 188,800 |
| TOTAL | $195,700 | $204,400 | $207,400 | $256,400 | $230,900 |
| Total Liabilities | $344,600 | $350,500 | $363,300 | $465,700 | $452,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,820 | 90,508 | 89,875 | 82,198 | 81,883 |
| Common Shares | 900 | 900 | 900 | 800 | 800 |
| Retained earnings | -692,200 | -655,500 | -629,500 | -598,300 | -537,000 |
| Other shareholders' equity | -4,000 | -4,200 | -3,700 | -5,300 | -5,400 |
| TOTAL | $740,500 | $760,000 | $783,200 | $683,400 | $735,200 |
| Total Liabilities And Equity | $1,085,100 | $1,110,500 | $1,146,500 | $1,149,100 | $1,187,200 |